About Journal

The Journal of Pharmacology & Pharmacotherapeutics (JPP) , a publication of Phcog.Net, is published by Medknow Publications and Media Pvt. Ltd. . It is a peer reviewed journal aiming to communicate high quality research articles, reviews and general articles in the field of pharmacology and pharmacotherapeutics. JPP is an open access, peer-reviewed and online & print journal that will encompass all aspects of basic research/clinical studies related to the field of pharmacology and pharmacotherapeutics. With the advancement of new technologies and the increasing expectation and demand from researchers, we are witnessing an enormous growth in pharmacology research. JPP provides a platform for exchange of new scientific information in the most precise and expeditious way to achieve timely dissemination of information and cross-fertilization of ideas. It is published QUARTERLY and available in both online and print versions.

Editorial Policy

Manuscripts are accepted with the understanding that the authors have not violated any ethical practice followed in preparation and publication of biomedical manuscripts. The list practices that are considered unethical are given in the journal website (www.jpharmacol.com). Author/s is/are responsible for all the statements made in their work and should be willing to defend them publicly, if challenged. Authors should prepare their manuscripts submitted to the journal exactly according to the instructions given. Manuscripts which do not follow the format and style of the journal may be returned to the authors for revision or rejected. The journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication. Manuscripts and figures are not returned to the authors, not even upon rejection of the paper .

Scope

JPP accepts, in English, Review articles, articles for Educational forum, Original research articles, Rapid communication and Research letter. Articles concerning fundamental and clinical aspects of pharmacology, chemotherapy, ethnopharmacology, pharmacoepidemiology and molecular pharmacology will be considered. Articles of general interest discussing methods, therapeutics, medical education, interesting websites, new drug information and commentary on a recent topic are also welcome.

Review articles and Educational forum
Review articles are written by researchers of considerable experience in the field concerned. The author should review the recent trend or advances in that field in the light of his own work. However, when an author has not done enough original work on a topic but nevertheless wants to share the knowledge on recent advances/trends which may be useful for post-graduate students, he may do so by writing an article for Educational Forum. The major portion of above articles should deal with the up-to date developments in the field in the last 3-5 years. Authors are advised to search Medline and other databases on the Internet, apart from collecting information using conventional methods.

Research papers
Original research work will be considered under this section depending on the volume and quality of work.

Methods
Articles on new methods/procedures on drug evaluation, testing and analyses will be published. Innovative studies on established methodologies and their modifications will also be considered. The articles must be supported by data.

Rapid communication
An article will be accepted for rapid communication if it merits priority publication. The decision of acceptance or otherwise will be communicated within 4 weeks of receipt of the manuscript and accepted articles will be published in the following issue.

Research letters
Preliminary work with hard data can be published as a Letter. Brief research communications will also be accepted under this section.

Correspondence
Comment(s) on previously published articles, items of current interest and articles of general interest and views can be submitted for this section.

Computers
Articles on computing and computer programs related to pharmacology research and/or teaching are welcome under this section. The source code (or the executable file) of the program must be sent in a diskette for evaluation. Articles describing commercial software related to pharmacology are also welcome.

Teaching aids
Reports on the innovative use of teaching aids are welcome under this section. The report must give adequate details so that others can try.

Case reports
The journal welcomes adverse drug reaction reporting and interesting case reports pertaining to pharmacotherapy.

Meeting reports
Conference (pharmacology) reports can be submitted for publication.

Web-wise
Interesting and useful websites can be reviewed under this section. Contact the Chief Editor for guidelines.

Molecules of the millennium
Information on new drugs under investigation can be published. Contact the Chief Editor for guidelines.

Fillers
The readers can send in brief write-ups for fillers. This may include anecdotes, pictures and photographs. If your proposed contribution does not fall under any of the above categories, please contact the Chief Editor.
 

Manuscript preparation

Manuscripts must conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” http://www.icmje.org/. Contributions and Manuscripts must be written in English. Manuscripts must be typewritten (double-spaced) with liberal margins and space at the top and bottom of the page. Manuscripts must be submitted by online manuscript management system only (See submission).

Covering Letter

Disclose all possible conflicts of interest (e.g. funding sources for consultancies or studies of products). Full contact details with postal address(es), phone numbers (mobile & landline) and email IDs (primary & secondary) of the corresponding author must be clearly mentioned. The importance of the paper may be briefly indicated. A list of potential reviewers (not exceeding 5) with their phone numbers and email IDs should be included. The suggested reviewers must be working in the same area dealt with in the manuscript. Whether to use their services or not is the discretion of the chief editor.

Copyright Form
All manuscripts are considered to be the property of Phcog.Net from the time of submission. If we are not publishing the paper, it releases its rights therein at the time the manuscript is rejected following the editorial/peer review or retracted by the authors. Manuscripts published in JPP become the sole property of the Phcog.Net. The corresponding author, on behalf of all authors, signs a copyright transfer form at the time of submission of the manuscript. Copyright Form can be downloaded from www.jpharmacol.com

 

Article Processing Charges w.e.f 1st Jan 2016 (Articles being published from Jan 1, 2016)

Phcog.Net Journals

Journal of Pharmacology and Pharmacotherapeutics is now supported by Phcog.Net and it is one of the Open Access Journals from Phcog.Net and officially published by Wolters Kluwer - Medknow.

 

Due to revised publishing charges, Articles clearing in peer review process or upon acceptance, Authors are required to pay a minimum of 1500 INR/PDF +14 % Service Tax for per Print Page - Final Format (Indian Authors) and 300 USD (Foreign Authors) towards pre-press charges. 

ARTICLE PROCESSING CHARGES

Authors from INDIA

No. of pages (Final PDF Version) - n	Chargeable Amount [INR] (1500 X n)	Service Tax @14% (Mandatory)	Total Amount to be paid [INR]
4	6000	840	6840
5	7500	1050	8550
6	9000	1260	10260
7	10500	1470	11970
8	12000	1680	13680
9	13500	1890	15390

*Articles with 3500 word length with 1 table & 1 Figure will approximately come up to 4 pages in final PDF version

*Minimum chargeable amount for publication is for 4 pages

For queries

Contact Editorial Office:

J Pharmacol. Pharmacother.

Phcog.Net
#17, II Floor, Buddha Vihar Road,
Cox Town, Bangalore, INDIA
560005

Ph: 080-65650760

E: [email protected]

Why do we charge?

This journal is an Open Access, where in the content is free to read. The journal is non-commercial and currently, it is self financing and not supported by any major organizations. Cost is being absorbed only with subscriptions. Hence, a nominal cost will be levied to cover the cost of the following

• Journal hosting systems [Wolters Kluwer -Medknow Publications and Media Pvt. Ltd., Mumbai]
• Manuscript submission systems [Journalonweb.com]
• In-house copyediting and linguistic support
• Pagination & typesetting
• Inclusion in Crossref, giving a permanent DOI and enabling easy citation in other journals.
• Archiving in Pubmed, where appropriate, in an internationally recognized, open access repositories.

---

Preparation of Manuscript

Title page should give the title, author’s names, their affiliations and their email IDs, corresponding author’s name, email IDs, postal address, phone numbers (landline & mobile) and acknowledgements if any.

Preparation of Manuscript

The manuscript should be typed, double-spaced on standardsized – paper (8.5" x 11") with 1" margins on all sides. Times New Roman font 12 pt should be used. The fonts used in the text as well as graphics should be restricted to Times New Roman, Symbol and Zapf Dingbats. A research paper typically should include the following in the order given below :

•    Title
•    Abstract
•    Keywords
•    Introduction
•    Materials and Methods
•    Results including Tables and/or Figures
•    Discussion
•    Conclusion
•    Acknowledgements (If any)
•    References
•    Appendixes (if necessary)
•    Abbreviations used (if necessary)

TITLE
Should be in Title Case; The first character in each word in the title has to be capitalized. Authors’ names and affiliations should not be given.

ABSTRACT
Should be structured and limited to 250 Words. A brief summary of the research should be given under the subheadings Introduction, Methods, Results, and Conclusions.

KEY WORDS
No more than six keywords are needed. Words appearing in the title should not be given as keywords. It is desirable to include the alternative words, if any under keywords e.g. the word ‘epinephrine’. They should be written left aligned, arranged alphabetically in 12pt Times Roman, and the line must begin with the words Keywords boldfaced. A 12pt space should separate the keywords from the affiliations.

INTRODUCTION
Description of the research area, pertinent background information, and the hypotheses tested in the study should be included under this section. The introduction should provide sufficient background information such that a scientifically literate reader can understand and appreciate the work to be described. A detailed review of literature is not at all required under this section. The specific aims of the project should be identified along with rationale for the specific experiments and other work performed. The introduction MUST include in-text citations including a few references pertinent to the background and justification for the study.

MATERIALS AND METHODS
Materials and/or subjects utilized in the study as well as the procedures undertaken to complete the work. The methods should be described in sufficient detail such that they could be repeated by a competent researcher. The sources of all major instruments and reagents used (kits, drugs, etc) must be given with parentheses. Illustrations and/or tables may be helpful in describing complex equipment or elaborate procedures. The statistical tool used to analyze the data should be mentioned. All procedures involving experimental animals or human subjects must accompany a statement on ethical approval from appropriate ethics committee.

RESULTS
Data acquired from the research with appropriate statistical analysis described in the methods section should be included in this section. The results section should highlight the important results obtained. Data should be organized into figures and tables. Qualitative as well as quantitative results should be included if applicable.

DISCUSSION/CONCLUSION
This section should relate the results section to current understanding of the scientific problems being investigated in the field. Description of relevant references to other work/s in the field should be included here. This section also allows the author to discuss the significance of the results - i.e. does the data support the hypotheses you set out to test? This section should end with new answers/questions that arise as a result of the author’s work.

TABLES AND FIGURES
Tables
Tables should be numbered with Roman numerals according to their sequence in the text, and have a short self-explanatory heading. Use SI units. Tables should include vertical rules, but horizontal rules should separate column headings from the content. Authors should keep in mind the page layout of the journal when designing tables. Tables that fit onto one printed page are preferred. Detailed explanations of symbols, units, and abbreviations should be given below the table.

Illustrations
Figures for final production should be submitted as electronic files and hard copy so that the editorial office can ensure that the output of electronic files matches the hardcopy. Please pay particular attention to the guidelines below. The editorial office cannot undertake preparation of manuscripts and illustrations not conforming to journal style. Manuscripts of insufficient quality will be returned immediately without refereeing. A high standard of illustration (both line and photo) is an editorial priority. All illustrations should be prepared for printing to fit 80 x 240 mm (column width) or 169 mm by up to 240 mm (full page) size. The authors should keep in mind that the full-page length is not used and the caption will be placed underneath the figure. In the event that full-page length is necessary for plates, captions will have to appear on adjacent pages. Figure(s) must be numbered consecutively in the text. Compound figures with more than one micrograph or photo should be referred by a single figure reference (e.g. Figure 1), and individual parts should be labeled with capitalized letters in the lower left-hand corner. Lettering should be of a sans-serif type (i.e. fonts without serifs such as Arial) with a minimum published size of 4.2 mm (12 pt). Descriptive labeling in the figures should be clearly readable, and all lettering should have a minimum published size of 6 pt (2.1 mm) for labeling items on photographs or in line art is recommended and a maximum size of 10 pt is suggested. Use a scale bar to indicate magnifications and place in the lower right corner if possible. Computer prepared photographic images must be at a minimum of 350 dpi at the final publication size. Lower resolution will result in pixilation and poor quality images. These should be submitted as JPEG or TIFF, but encapsulated postscript (EPS) format is also acceptable. Computer drawn figures are accepted provided they are of high quality. Please note that graphs produced by many statistical packages are rarely adequate. In particular, letter quality on axes and captions are often poor. Such figures should be exported into an accepted graphics package and lettering rendered using a text function. Authors should note that .dot, .bmp, and .pat fills should be avoided. Do not use postscript fill patterns as these are often based on bit map patterns that result in screening patterns during final reproduction. When filling illustrations, use fills such as lines, tints or solids. Line width minimum is 0.25 pt (0.09 mm). Also avoid the use of bitmap scans to render text and detail. Text should be saved as text at a minimum text size of 6 pt (2.1 mm). Submit line art as Corel Draw, Adobe Illustrator, or EPS files. These must be at a minimum resolution of 800 DPI at publication size. High resolution may be necessary where fine line detail is present. For graphs, Excel graphs are also acceptable. Note that vertical axes must all be at the same scale especially when the paper compares them. Otherwise they should be produced as separate figures. Avoid 3D plots when presenting 2D data. All tables and figures must be placed in appropriate places in the manuscript and when this is not possible, appropriate place must be indicated in the manuscript. Please note good quality figures must be submitted as separate files as said above apart from presenting a copy of the same at appropriate places in the manuscript. This will make job of the reviewer easy.

TABLE AND FIGURE CAPTIONS
Figure captions/legends should include a statement at the end of each caption/legend about reproduction size (e.g. at full page width, at column width). They should be single spaced and typed in the journal format. Explanations should be brief and authors should keep in mind that captions/legends will be placed below figures.

ACKNOWLEDGEMENTS
Those who have helped the authors carry out the study and/ or prepare the manuscript but have not made significant intellectual contribution to deserve authorship must be acknowledged. Mention all applicable grants and other funding that supported the work.
All text should be fully justified. Please put all primary section titles in UPPER CASE letters and subheading in both Upper and Lower Case letters. Do not number your titles (for example, 1.0 Introduction; 2.0 Background). Do not use the tab key to indent blocks of text such as paragraphs of quotes or lists because the page layout program overrides the left margin with its own, and the tabs end up in mid-sentence.

GUIDELINES
Authors reporting in vivo animal experiments and clinical trials are encouraged to refer to the ARRIVE guidelines (http://www.jpharmacol.com/text.asp?2010/1/2/94/72351) and the CONSORT statement (http://www.jpharmacol.com/text.asp?2010/1/2/100/72352) respectively and use the checklists given within them to improve the quality of the manuscripts. The checklists (Animal Experiments,  Clinical Trial) must be downloaded, filled in and submitted along with the manuscripts. This would not only help the authors to include all the important information while preparing the manuscript but also speed up the peer review process.

PROTECTION OF PATIENTS' RIGHT TO PRIVACY

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines:

1)    Authors, not the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.

2)    If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.

Page layout & styles

Page size	Letter Portrait 8 ½ X 11
Margins	All Margins, 1cm
Page number	Numbered at bottom right
Footer / Headers	None
Title	14 pt Times New Roman, bold, centered.
Author and co-authors	12 pt Times New Roman centered, bold - author and all co-authors names in one line. The corresponding author should include an asterisk*.
Authors address	12 pt Times New roman centered - giving each authors' affiliation (i.e. Department/Organization/Address/Place/Country/email). Followed by single line spacing. Author for Correspondence: 10pt Times New roman centered - giving a valid e-mail of the corresponding (main) author is a must. It should be indicated as* followed by two line spacing.
Abstract	12 pt Times New roman, full justification Normal - maximum 250 words
Text	12 pt Times New roman, full justification – 1.5 line spacing between paragraphs. No indentation
Heading	Major headings (ABSTRACT, KEYWORDS, INTRODUCTION, MATERIALS AND METHODS, RESULTS AND DISCUSSION, ACKNOWLEDGEMENTS, REFERENCES) in upperr case left-justified, 12 pt bold, Intermediate headings should be in italics, sentence case, left justified, 12 pt
Tables	To be incorporated at the end of Manuscript Correct “Table 1 : Serum enzyme levels………” Incorrect “Table No. 1 : Serum enzyme levels………”
Figures /Graphs	Figures may be embedded in your word document but they should be created with a program that allows you to save them as gif, jpg or tiff format. Figures, tables or other materials copied verbatim or adopted from previously published materials, the author must have written permission from the the copyright holder of that material (publisher and/or authors) for reproduction in your article. A copy of the permission release must be submitted with the manuscript. It is the author's responsibility to obtain permission. To be incorporated at the end of the manuscript with proper labeling Correct “Figure 1 : Serum enzyme levels………” Incorrect “Figure No. 1 : Serum enzyme levels………”
Graphs	To be included from excel and it should be editable. Non–editable graphs will not be accepted.

All text should be fully justified. Please put all primary section titles in UPPER CASE letters and subheading in both Upper and Lower Case letters. Do not number your titles (for example, 1.0 Introduction; 2.0 Background). Do not use the tab key to indent blocks of text such as paragraphs of quotes or lists because the page layout program overrides the left margin with its own, and the tabs end up in mid-sentence.

References

In-text citation

Correct / Acceptable Format
Natural products have proven to be a great source of new biologically active compounds. Thus, in an effort to discover new lead anti-malarial compounds, several research groups screen plant extracts to detect secondary metabolites with relevant biological activities that could serve as templates for the development of new drugs. Flavonoids have been isolated and characterized from many medicinal plants used in malaria endemic areas. ^[10] However, controversial data have been obtained regarding their antiplasmodial activity, probably because of their structural diversity. ^[11-13] More recently, several flavonoids have been isolated from Artemisia afra ^[14,16] and Artemisia indica, ^[17-20] two plants related to Artemisia annua, the famous traditional Chinese medicinal plant from which artemisinin is isolated.

Incorrect / Not accepted
Natural products have proven to be a great source of new biologically active compounds. Thus, in an effort to discover new lead anti-malarial compounds, several research group screen plant extracts to detect secondary metabolites with relevant biological activities that could served as templates for the development of new drugs. Flavonoids have been isolated and characterized from many medicinal plants used in malaria endemic areas. (10). However, controversial data have been obtained regarding their antiplasmodial activity, probably because of their structural diversity (11, 12, 13). More recently, several flavonoids have been isolated from Artemisia afra14 and Artemisia indica (15), two plants related to Artemisia annua, the famous traditional Chinese medicinal plant from which artemisinin is isolated.

Reference List: Author/Authors

JOURNAL REFERENCES

1. Single/Multiple Authors
   
   Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4): 284-7.
    
2. More than six authors
   
   Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002; 935(1-2): 40-6.
    
3. Organization as Author
   
   Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002; 40(5): 679-86.
    
4. Unknown Author
   
   21st century heart solution may have a sting in the tail. BMJ. 2002; 325(7357): 184-5.
    
5. Journal article on the Internet
   
   Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12]; 102(6): [about 3 p.]. Available from:
   
   http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
   
   Note: Plant/Micro organisms, in-vivo, in-vitro should be in italics.
    
6. Personal author(s)
   
   Murray PR, Rosenthal KS, Kobayashi GS, Paller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.
    
7. Editor(s), compiler(s) as author
   
   Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
    
8. Author(s) and editor(s)
   
   Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.
    
9. Organization(s) as author
   
   Royal Adelaide Hospital; University of Adelaide, Department of Clinical Nursing. Compendium of nursing research and practice development, 1999-2000. Adelaide (Australia): Adelaide University; 2001.
    
10.  Chapter in a book
    
    Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
     
11. Conference proceedings
    
    Harnden P, Joffe JK, Jones WG, editors. Germ cell tumors V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
     
12.  Thesis
    
    N. Khoshakhlagh. The compositions of volatile fractions of Peganum harmala seeds and its smoke. Pharm. D. Thesis, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. (2002).
     
13.  WEBSITES
    
    Website information
    Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/.

 

Limitations for papers submitted under each category

Article type	Abstract: No. of words	Key words: No. of words	Running title: No. of characters	Text: No. of words	Sub-headings	Tables & No. of figures: max. No	References
RA & EF	< 250	3-5	< 50	< 6400	Variable	Total of ten	< 100
RP	< 250	3-5	< 50	< 3200	Standard	Total of six	< 30
ME	< 150	3-5	< 50	< 1600	Standard	Total of four	< 20
RC	NR	NR	< 50	< 1200	No SH	Total of two	< 10
LE	NR	NR	< 50	< 800	No SH	Total of two	< 6
CO	NR	NR	< 50	< 1400	Variable	Total of two	< 6
CP	NR	NR	< 50	< 1400	Variable	Total of two	< 6
TA	NR	NR	< 50	< 1400	Variable	Total of two	< 6
CR	NR	NR	< 50	< 1400	Variable	Total of two	< 6

RA=Review Article; EF-Educational Forum; RP=Research Paper; RC=Rapid Communication; ME=Methods; LE=Research Letter; CO=Correspondence; CP=Computer; TA=Teaching Aid; CR=Case Report; NR=Not Required; SH=Sub-headings.

Acknowledgements

All messages and reviews sent electronically will be acknowledged automatically upon receipt. Note: Do not send hard copies/CDs, until you receive e-mail request from Editorial office. A timely submission, however, is not a guarantee that your work will be accepted for forthcoming publication. All submissions are peer reviewed by the editorial board and a select group of reviewers. Please make sure that all guidelines are followed carefully. All the accepted articles will be queued for publication and will appear in the futures issues based on the priorities set by the editorial board. The manuscript should be submitted through Web Based Manuscript Submission at www.journalonweb.com/jpp ONLY. Hard copies are not accepted.

Submission of manuscript

Manuscripts should always be submitted only Web based Manuscript Submission Systems. http://www.journalonweb.com/jpp


The manuscript should be submitted through Web Based Manuscript Submission at www.journalonweb.com/jpp ONLY. Hard copies are not being accepted.

Check List for Submitting A Manuscript

• Covering letter (first page)
• Copyright Forms (Scanned)
• Manuscript
• Illustrations (if any)

Book Reviews

Send two hard copies of your book to the following address;

The Editor in Chief,
J Pharmacol Pharmacother
Dept of Pharmacology
JIPMER
Pondicherry - 605006
INDIA

 

Author Checklist for Sending Proofs to Editorial Office

In order to maintain quality and consistency in Phcog.Net publications, we ask you to check the following prior to submitting the final proof for publication:

• Include the original, hard copy of Author’s Transfer of Copyright signed by each author
• Thoroughly check the reference style as mentioned above.
• Thoroughly check the article for correct grammar, in particular: spelling of names, affiliations, any symbols, equations, etc.
• Provide laser printed hard copies of all figures and graphics in black and white or colour (If any)
• Submit a proof corrected with RED INK ONLY or as directed by the editor handling your manuscript.

Send the Corrected Proof, Copyright Transfer Form, Subscriptions (If any) with covering letter in a single envelope to the following address

Note : e-mails with vicious language, offensive writings to Editors will lead to rejection of the manuscript.

Status of Manuscript

The corresponding author can check the status of the submitted manuscript on the journal website.

Important e-mail IDs

J Pharmacol Pharmacother

Submissions	: www.journalonweb.com/jpp
Queries	: editor @ jpharmacol . com
(Queries will be replied in two working days)
Other correspondence	: editor @ jpharmacol . com
Chief Editor	: editor @ jpharmacol . com
URL :
Journal Site	: www.jpharmacol.com
Contact Journal Office: J Pharmacol. Pharmacother. Phcog.Net #17, II Floor, Buddha Vihar Road, Cox Town, Bangalore, INDIA 560005 Ph: 080-65650760 E: [email protected]

 

Click here to download instructions

Click here to download copyright form

These ready to use templates are made to help the contributors write as per the requirements of the Journal.

Save the templates on your computer and use them with a word processor program. 
Click open the file and save as the manuscript file.

In the program keep 'Document Map' and 'Comments' on from 'View' menu to navigate through the file. 


Download Template for Original Articles/ABSTRACT Reports. (.DOT file)

Download Template for Case Reports.  (.DOT file)

Download Template for Review Articles.  (.DOT file)

Download Template for Letter to the Editor.  (.DOT file)